Abstract
Background and aims: Atopic eczema generates a high economic burden, eg. 1.2-3.5 billion € per annum in Germany. The GINI trial, a prospective, randomized, double-blind intervention study in Germany that recruited a cohort of 2,252 infants with parental and/or sibling-related heredity for atopy between 1995 and 1998 showed that children fed with certain hydrolysate formulas at least the first four months of life have a reduction of the relative risk for atopic dermatitis by 26-45% compared to a cow's milk formula. The objective of this study was to assess the cost-effectiveness of feeding hydrolysate formulas in the prevention of atopic eczema.
Methods: Cost-effectiveness was assessed with a decision tree model programmed with the software TreeAge. Children were followed over a 6 year period. Costs and effects were analyzed using the perspective of the German statutory health insurance (SHI) and a societal perspective.
Results: In the base case scenario both the partial whey hydrolysate and the extensively hydrolysed casein formula-feeding are cost-effective in preventing infantile atopic eczema from a societal perspective. In the sixth year both formulas generated cost-savings. From the SHI perspective, the extensively hydrolysed casein formula was cost-effective and the partial whey hydrolysate cost-saving after six years. The third formula, an extensively hydrolysed whey formula, was dominated in both analyses.
Conclusion: Our results show that for the prevention of atopic eczema two formulas can be cost-effective or even cost-saving depending on the scenario.
Economic studies indicate that atopic dermatitis generates a high economic burden.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mertens, J., Stock, S., Lüngen, M. et al. 126 Is Prevention of Atopic Dermatitis with Hydrolysate Formulas Cost Effective? An Application of Results of the Gini-Study to the German Situation. Pediatr Res 68 (Suppl 1), 66–67 (2010). https://doi.org/10.1203/00006450-201011001-00126
Issue Date:
DOI: https://doi.org/10.1203/00006450-201011001-00126